Yoshiki Shigematsu - Concepedia

Author

Yoshiki Shigematsu

University of Occupational and Environmental Health Japan

Also Known As

Y. Shigematsu, YOSHIKI SHIGEMATSU, Yoshiki SHIGEMATSU, Yoshiki Shigematsu

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

University of Occupational and Environmental Health Japan Ichinomiya Kenshin College Nagoya University Kitasato University Medical Center Aichi Cancer Center

About

Yoshiki Shigematsu is an author at University of Occupational and Environmental Health Japan specializing in medicine, oncology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	544
2	Health Sciences	3	3	107
3	Public Health	1	1	23
4	Cell Biology	1	1	32
5	Epidemiology	1	1	23

Yoshiki Shigematsu

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer Yoshiki Shigematsu, Takeshi Hanagiri, Hironobu Shiota, Lung Cancer Cancer ImmunosurveillanceMedicineMultiple Pulmonary NoduleImmunologyPathology	2009	116
Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters Mamoru Takahashi, Yoshiki Shigematsu, Makoto Ohta, Journal of Thoracic and Cardiovascular Surgery Cancer DetectionMedicineIaslc/ats/ers ClassificationTumor InvasivenessPathology	2013	105
Preoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer Takeshi Hanagiri, Masakazu Sugaya, Masaru Takenaka, Lung Cancer Prognostic FactorsCell Lung CancerAdvanced Lung DiseaseMedicinePreoperative Cyfra 21-1	2011	82
Cytokine production of lung cancer cell lines: Correlation between their production and the inflammatory/immunological responses both <i> in vivo</i> and <i>in vitro</i> Takashi Fukuyama, Yoshinobu Ichiki, Sousuke Yamada, Cancer Science	2007	78
Results of a Surgical Resection for Patients With Stage IV Non–Small-Cell Lung Cancer Takeshi Hanagiri, Masaru Takenaka, Soich Oka, Clinical Lung Cancer Surgical OncologySurgical ResectionMedicineBronchial NeoplasmThoracic Surgery	2011	52
The prognostic significance of HER2 overexpression in non-small cell lung cancer. Masaru Takenaka, Takeshi Hanagiri, Shinji Shinohara, PubMed	2011	38
New evaluation of the tumor immune microenvironment of non-small cell lung cancer and its association with prognosis Shuichi Shinohara, Yusuke Takahashi, Hiroyasu Komuro, Journal for ImmunoTherapy of Cancer	2022	35
Lack and restoration of sensitivity of lung cancer cells to cellular attack with special reference to expression of human leukocyte antigen class I and/or major histocompatibility complex class I chain related molecules A/B Tetsuro Baba, Takeshi Hanagiri, Yoshinobu Ichiki, Cancer Science	2007	34
Clinical significance of the frequency of regulatory T cells in regional lymph node lymphocytes as a prognostic factor for non-small-cell lung cancer Takeshi Hanagiri, Yoshiki Shigematsu, Shinji Shinohara, Lung Cancer Lymphoid NeoplasiaCancer ImmunosurveillanceNon-small-cell Lung CancerMedicineT-regulatory Cell	2013	33
Immunosuppressive effect of regulatory T lymphocytes in lung cancer, with special reference to their effects on the induction of autologous tumor-specific cytotoxic T lymphocytes Yoshiki Shigematsu, Takeshi Hanagiri, Hironobu Shiota, Oncology Letters T-regulatory CellImmunologyImmunoeditingRegulatory T CellsImmunotherapy	2012	32

Page 1